| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 1.62e-05 | 25 | 124 | 4 | GO:0017056 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 2.23e-05 | 27 | 124 | 4 | GO:0008139 | |
| GeneOntologyMolecularFunction | signaling adaptor activity | 1.55e-04 | 129 | 124 | 6 | GO:0035591 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | DAB2IP ASXL1 ANK2 ANK3 RIPK1 MAP1A NACA BRD3 SHANK2 KHDRBS1 MAVS MDC1 HGS EIF4G1 SLMAP PXN TAF9 SPEN PCM1 DNMT3A | 2.55e-04 | 1356 | 124 | 20 | GO:0060090 |
| GeneOntologyMolecularFunction | cadherin binding | 2.70e-04 | 339 | 124 | 9 | GO:0045296 | |
| GeneOntologyMolecularFunction | signal sequence binding | 2.82e-04 | 51 | 124 | 4 | GO:0005048 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 2.86e-04 | 93 | 124 | 5 | GO:0097110 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | DAB2IP ASXL1 ANK2 ANK3 RIPK1 MAP1A NACA BRD3 SHANK2 KHDRBS1 MAVS MDC1 HGS SLMAP PXN TAF9 SPEN DNMT3A | 2.92e-04 | 1160 | 124 | 18 | GO:0030674 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | DAB2IP ANK3 NLGN4Y COBLL1 SH3GLB2 EPS8L1 NLGN4X ANLN AHNAK PXN NUMB MACF1 | 3.57e-04 | 599 | 124 | 12 | GO:0050839 |
| GeneOntologyMolecularFunction | cytoskeletal anchor activity | 4.30e-04 | 24 | 124 | 3 | GO:0008093 | |
| GeneOntologyMolecularFunction | ATPase binding | 5.70e-04 | 108 | 124 | 5 | GO:0051117 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase activity | 6.13e-04 | 27 | 124 | 3 | GO:0004709 | |
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 1.05e-03 | 8 | 124 | 2 | GO:0098882 | |
| GeneOntologyMolecularFunction | protein kinase binding | DAB2IP ANK2 CEP192 CHRNA7 SPRED3 PTPRC KHDRBS1 MAVS PXN LRP4 MAP3K13 RAPGEF2 CHRFAM7A MUSK | 1.05e-03 | 873 | 124 | 14 | GO:0019901 |
| GeneOntologyMolecularFunction | spectrin binding | 1.22e-03 | 34 | 124 | 3 | GO:0030507 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL6A3 ANK2 ANK3 MAP1A PCLO NUP214 POM121C SHANK2 AHNAK NPAP1 H1-5 MACF1 BSN POM121B | 1.28e-03 | 891 | 124 | 14 | GO:0005198 |
| GeneOntologyMolecularFunction | phosphorylation-dependent protein binding | 1.67e-03 | 10 | 124 | 2 | GO:0140031 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.83e-03 | 206 | 124 | 6 | GO:0140030 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 2.25e-03 | 42 | 124 | 3 | GO:0098918 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | ANK2 MCPH1 MAP1A NACA BRD3 NUP214 CEP192 CHGA POM121C PXK GFY FSIP2 SETD2 MAVS MDC1 HGS NPAP1 VPS13A H1-5 MACF1 TMEM108 POM121B PCM1 | 1.09e-07 | 1091 | 123 | 23 | GO:0033365 |
| GeneOntologyBiologicalProcess | cell junction organization | DAB2IP ABL2 ANK2 ANK3 NLGN4Y PCLO CHRNA7 SHANK2 NLGN4X EIF4G1 PKHD1 PXN LRP4 NUMB MACF1 TMEM108 RAPGEF2 BSN IGSF21 CHRFAM7A MUSK | 2.93e-07 | 974 | 123 | 21 | GO:0034330 |
| GeneOntologyBiologicalProcess | synapse organization | DAB2IP ABL2 ANK3 NLGN4Y PCLO CHRNA7 SHANK2 NLGN4X EIF4G1 LRP4 NUMB TMEM108 RAPGEF2 BSN IGSF21 CHRFAM7A MUSK | 6.69e-07 | 685 | 123 | 17 | GO:0050808 |
| GeneOntologyBiologicalProcess | presynapse assembly | 1.53e-06 | 60 | 123 | 6 | GO:0099054 | |
| GeneOntologyBiologicalProcess | RNA export from nucleus | 1.73e-06 | 96 | 123 | 7 | GO:0006405 | |
| GeneOntologyBiologicalProcess | neuron projection arborization | 2.98e-06 | 38 | 123 | 5 | GO:0140058 | |
| GeneOntologyBiologicalProcess | presynapse organization | 4.89e-06 | 73 | 123 | 6 | GO:0099172 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | MAP1A NLGN4Y PCLO PXK CHRNA7 SHANK2 NLGN4X VPS13A HRH1 TMEM108 RAPGEF2 BSN IGSF21 CHRFAM7A MUSK | 9.75e-06 | 663 | 123 | 15 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | MAP1A NLGN4Y PCLO PXK CHRNA7 SHANK2 NLGN4X VPS13A HRH1 TMEM108 RAPGEF2 BSN IGSF21 CHRFAM7A MUSK | 9.92e-06 | 664 | 123 | 15 | GO:0099177 |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by baroreceptor feedback | 1.13e-05 | 8 | 123 | 3 | GO:0003025 | |
| GeneOntologyBiologicalProcess | postsynapse organization | ABL2 NLGN4Y CHRNA7 SHANK2 NLGN4X LRP4 NUMB TMEM108 CHRFAM7A MUSK | 1.85e-05 | 313 | 123 | 10 | GO:0099173 |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 2.41e-05 | 10 | 123 | 3 | GO:0097105 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | DAB2IP ASXL1 ABL2 ANK3 MAP1A SYT2 PRAG1 ATP10A ZEB2 CHRNA7 VPS13A PKHD1 PXN LRP4 NUMB MACF1 TMEM108 MAP3K13 RAPGEF2 CHRFAM7A | 2.56e-05 | 1194 | 123 | 20 | GO:0000902 |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 3.30e-05 | 11 | 123 | 3 | GO:0097104 | |
| GeneOntologyBiologicalProcess | endocytosis | ABL2 ANK2 ANK3 NLGN4Y SH3GLB2 SYT2 CHRNA7 PTPRC NLGN4X HGS LRP4 NUMB TMEM108 CHRFAM7A ARHGAP21 GULP1 | 3.31e-05 | 827 | 123 | 16 | GO:0006897 |
| GeneOntologyBiologicalProcess | positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure | 3.53e-05 | 2 | 123 | 2 | GO:0001988 | |
| GeneOntologyBiologicalProcess | cell junction assembly | ANK2 NLGN4Y PCLO SHANK2 NLGN4X EIF4G1 PXN LRP4 NUMB MACF1 RAPGEF2 BSN MUSK | 3.59e-05 | 569 | 123 | 13 | GO:0034329 |
| GeneOntologyBiologicalProcess | learning | 4.09e-05 | 212 | 123 | 8 | GO:0007612 | |
| GeneOntologyBiologicalProcess | modulation of excitatory postsynaptic potential | 4.31e-05 | 65 | 123 | 5 | GO:0098815 | |
| GeneOntologyBiologicalProcess | microtubule-based process | SPEM3 ANK3 MCPH1 MAP1A TACC2 CEP192 CCDC57 CHRNA7 FSIP2 SETD2 VPS13A PKHD1 MACF1 TMEM108 BSN CHRFAM7A ARHGAP21 PCM1 | 5.57e-05 | 1058 | 123 | 18 | GO:0007017 |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 5.67e-05 | 13 | 123 | 3 | GO:0097090 | |
| GeneOntologyBiologicalProcess | aggressive behavior | 5.67e-05 | 13 | 123 | 3 | GO:0002118 | |
| GeneOntologyBiologicalProcess | cell proliferation in forebrain | 7.60e-05 | 38 | 123 | 4 | GO:0021846 | |
| GeneOntologyBiologicalProcess | social behavior | 8.06e-05 | 74 | 123 | 5 | GO:0035176 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | DAB2IP ABL2 ANK3 MAP1A SYT2 ZEB2 CHRNA7 VPS13A LRP4 NUMB MACF1 TMEM108 MAP3K13 RAPGEF2 CHRFAM7A | 8.69e-05 | 802 | 123 | 15 | GO:0048812 |
| GeneOntologyBiologicalProcess | RNA transport | 8.72e-05 | 175 | 123 | 7 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 8.72e-05 | 175 | 123 | 7 | GO:0050657 | |
| GeneOntologyBiologicalProcess | biological process involved in intraspecies interaction between organisms | 9.15e-05 | 76 | 123 | 5 | GO:0051703 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 9.70e-05 | 178 | 123 | 7 | GO:0051236 | |
| GeneOntologyBiologicalProcess | synapse assembly | 9.76e-05 | 308 | 123 | 9 | GO:0007416 | |
| GeneOntologyBiologicalProcess | baroreceptor response to decreased systemic arterial blood pressure | 1.05e-04 | 3 | 123 | 2 | GO:0001982 | |
| GeneOntologyBiologicalProcess | territorial aggressive behavior | 1.05e-04 | 3 | 123 | 2 | GO:0002124 | |
| GeneOntologyBiologicalProcess | presynapse to nucleus signaling pathway | 1.05e-04 | 3 | 123 | 2 | GO:0099526 | |
| GeneOntologyBiologicalProcess | positive regulation of protein phosphorylation | DAB2IP RIPK1 CHGA ZEB2 CHRNA7 PTPRC MAVS EIF4G1 PXN LRP4 MAP3K13 RAPGEF2 CHRFAM7A MUSK | 1.07e-04 | 724 | 123 | 14 | GO:0001934 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | DAB2IP ABL2 ANK3 MAP1A SYT2 ZEB2 CHRNA7 VPS13A LRP4 NUMB MACF1 TMEM108 MAP3K13 RAPGEF2 CHRFAM7A | 1.10e-04 | 819 | 123 | 15 | GO:0120039 |
| GeneOntologyBiologicalProcess | regulation of synapse organization | DAB2IP CHRNA7 SHANK2 NLGN4X EIF4G1 LRP4 NUMB RAPGEF2 CHRFAM7A MUSK | 1.10e-04 | 387 | 123 | 10 | GO:0050807 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | DAB2IP ABL2 ANK3 MAP1A SYT2 ZEB2 CHRNA7 VPS13A LRP4 NUMB MACF1 TMEM108 MAP3K13 RAPGEF2 CHRFAM7A | 1.20e-04 | 826 | 123 | 15 | GO:0048858 |
| GeneOntologyBiologicalProcess | nuclear export | 1.23e-04 | 185 | 123 | 7 | GO:0051168 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 1.26e-04 | 249 | 123 | 8 | GO:0015931 | |
| GeneOntologyBiologicalProcess | associative learning | 1.30e-04 | 130 | 123 | 6 | GO:0008306 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | DAB2IP CHRNA7 SHANK2 NLGN4X EIF4G1 LRP4 NUMB RAPGEF2 CHRFAM7A MUSK | 1.30e-04 | 395 | 123 | 10 | GO:0050803 |
| GeneOntologyBiologicalProcess | behavioral response to ethanol | 1.32e-04 | 17 | 123 | 3 | GO:0048149 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | MAP1A NLGN4Y PCLO SYT2 PXK CHRNA7 SHANK2 NLGN4X VPS13A HRH1 TMEM108 RAPGEF2 BSN IGSF21 CHRFAM7A MUSK | 1.33e-04 | 931 | 123 | 16 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | MAP1A NLGN4Y PCLO SYT2 PXK CHRNA7 SHANK2 NLGN4X VPS13A HRH1 TMEM108 RAPGEF2 BSN IGSF21 CHRFAM7A MUSK | 1.33e-04 | 931 | 123 | 16 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | MAP1A NLGN4Y PCLO SYT2 PXK CHRNA7 SHANK2 NLGN4X VPS13A HRH1 TMEM108 RAPGEF2 BSN IGSF21 CHRFAM7A MUSK | 1.47e-04 | 939 | 123 | 16 | GO:0099537 |
| GeneOntologyBiologicalProcess | microtubule-based movement | SPEM3 ANK3 MAP1A CHRNA7 FSIP2 VPS13A TMEM108 BSN CHRFAM7A ARHGAP21 PCM1 | 1.81e-04 | 493 | 123 | 11 | GO:0007018 |
| GeneOntologyBiologicalProcess | brain development | DAB2IP SOX11 ABL2 MCPH1 NLGN4Y TACC2 ZEB2 SETD2 NLGN4X NAV2 SMG9 NUMB TMEM108 RAPGEF2 PCM1 | 1.85e-04 | 859 | 123 | 15 | GO:0007420 |
| GeneOntologyBiologicalProcess | generation of ovulation cycle rhythm | 2.10e-04 | 4 | 123 | 2 | GO:0060112 | |
| GeneOntologyBiologicalProcess | male courtship behavior | 2.10e-04 | 4 | 123 | 2 | GO:0008049 | |
| GeneOntologyBiologicalProcess | presynaptic signal transduction | 2.10e-04 | 4 | 123 | 2 | GO:0098928 | |
| GeneOntologyBiologicalProcess | import into cell | ABL2 ANK2 ANK3 NLGN4Y SH3GLB2 SYT2 CHRNA7 PTPRC NLGN4X HGS LRP4 NUMB TRPV3 TMEM108 CHRFAM7A ARHGAP21 GULP1 | 2.17e-04 | 1074 | 123 | 17 | GO:0098657 |
| GeneOntologyBiologicalProcess | adult behavior | 2.19e-04 | 203 | 123 | 7 | GO:0030534 | |
| GeneOntologyBiologicalProcess | regulation of nucleobase-containing compound transport | 2.19e-04 | 20 | 123 | 3 | GO:0032239 | |
| GeneOntologyBiologicalProcess | synaptic signaling | MAP1A NLGN4Y PCLO SYT2 PXK CHRNA7 SHANK2 NLGN4X VPS13A HRH1 TMEM108 RAPGEF2 BSN IGSF21 CHRFAM7A MUSK | 2.28e-04 | 976 | 123 | 16 | GO:0099536 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | DAB2IP RIPK1 CHGA ZEB2 CHRNA7 PTPRC MAVS EIF4G1 PXN LRP4 MAP3K13 RAPGEF2 CHRFAM7A MUSK | 2.32e-04 | 780 | 123 | 14 | GO:0042327 |
| GeneOntologyBiologicalProcess | negative regulation of ERK1 and ERK2 cascade | 2.62e-04 | 95 | 123 | 5 | GO:0070373 | |
| GeneOntologyBiologicalProcess | behavior | ABL2 MAP1A NLGN4Y CHRNA7 SHANK2 NLGN4X EIF4G1 VPS13A NAV2 HRH1 CHRFAM7A UNC79 MUSK PCM1 NPAS2 | 2.73e-04 | 891 | 123 | 15 | GO:0007610 |
| GeneOntologyBiologicalProcess | RNA localization | 3.28e-04 | 217 | 123 | 7 | GO:0006403 | |
| GeneOntologyBiologicalProcess | membrane depolarization during cardiac muscle cell action potential | 3.36e-04 | 23 | 123 | 3 | GO:0086012 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane organization | 3.48e-04 | 56 | 123 | 4 | GO:0001941 | |
| GeneOntologyBiologicalProcess | sensory processing | 3.49e-04 | 5 | 123 | 2 | GO:0050893 | |
| GeneOntologyBiologicalProcess | presynaptic active zone assembly | 3.49e-04 | 5 | 123 | 2 | GO:1904071 | |
| GeneOntologyBiologicalProcess | soft palate development | 3.49e-04 | 5 | 123 | 2 | GO:0060023 | |
| GeneOntologyBiologicalProcess | regulation of synaptic plasticity | 3.79e-04 | 293 | 123 | 8 | GO:0048167 | |
| GeneOntologyBiologicalProcess | head development | DAB2IP SOX11 ABL2 MCPH1 NLGN4Y TACC2 ZEB2 SETD2 NLGN4X NAV2 SMG9 NUMB TMEM108 RAPGEF2 PCM1 | 3.79e-04 | 919 | 123 | 15 | GO:0060322 |
| GeneOntologyBiologicalProcess | vocalization behavior | 3.82e-04 | 24 | 123 | 3 | GO:0071625 | |
| GeneOntologyBiologicalProcess | retrograde axonal transport | 3.82e-04 | 24 | 123 | 3 | GO:0008090 | |
| GeneOntologyBiologicalProcess | nervous system process involved in regulation of systemic arterial blood pressure | 3.82e-04 | 24 | 123 | 3 | GO:0001976 | |
| GeneOntologyBiologicalProcess | learning or memory | 4.04e-04 | 373 | 123 | 9 | GO:0007611 | |
| GeneOntologyBiologicalProcess | response to ethanol | 4.13e-04 | 161 | 123 | 6 | GO:0045471 | |
| GeneOntologyBiologicalProcess | protein localization to microtubule cytoskeleton | 4.25e-04 | 59 | 123 | 4 | GO:0072698 | |
| GeneOntologyBiologicalProcess | negative regulation of proteasomal protein catabolic process | 4.83e-04 | 61 | 123 | 4 | GO:1901799 | |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | 5.08e-04 | 385 | 123 | 9 | GO:0070372 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback | 5.21e-04 | 6 | 123 | 2 | GO:0001978 | |
| GeneOntologyBiologicalProcess | regulation of membrane depolarization during cardiac muscle cell action potential | 5.21e-04 | 6 | 123 | 2 | GO:1900825 | |
| GeneOntologyBiologicalProcess | maintenance of presynaptic active zone structure | 5.21e-04 | 6 | 123 | 2 | GO:0048790 | |
| GeneOntologyBiologicalProcess | protein localization to cytoskeleton | 5.47e-04 | 63 | 123 | 4 | GO:0044380 | |
| GeneOntologyBiologicalProcess | membrane assembly | 5.80e-04 | 64 | 123 | 4 | GO:0071709 | |
| GeneOntologyBiologicalProcess | neuron projection development | DAB2IP ABL2 ANK3 MAP1A SYT2 ADGRV1 PRAG1 ZEB2 CHRNA7 VPS13A LRP4 NUMB MACF1 TMEM108 MAP3K13 RAPGEF2 CHRFAM7A MUSK | 6.09e-04 | 1285 | 123 | 18 | GO:0031175 |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | 6.90e-04 | 321 | 123 | 8 | GO:0099003 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular signal transduction | DAB2IP SOX11 ASXL1 ABL2 ANK3 RIPK1 CHGA ADGRV1 PRAG1 ZEB2 CHRNA7 PTPRC MAVS LRP4 MAP3K13 RAPGEF2 CHRFAM7A MUSK | 6.90e-04 | 1299 | 123 | 18 | GO:1902533 |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | DAB2IP RIPK1 ZEB2 CHRNA7 PTPRC PXN MAP3K13 RAPGEF2 CHRFAM7A MUSK | 7.15e-04 | 490 | 123 | 10 | GO:0051347 |
| GeneOntologyBiologicalProcess | courtship behavior | 7.26e-04 | 7 | 123 | 2 | GO:0007619 | |
| GeneOntologyBiologicalProcess | regulation of membrane depolarization during action potential | 7.26e-04 | 7 | 123 | 2 | GO:0098902 | |
| GeneOntologyBiologicalProcess | central nervous system development | DAB2IP SOX11 ABL2 MCPH1 NLGN4Y TACC2 ZEB2 SETD2 NLGN4X VPS13A NAV2 SMG9 NUMB TMEM108 RAPGEF2 PCM1 NPAS2 | 7.49e-04 | 1197 | 123 | 17 | GO:0007417 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | DAB2IP ABL2 EPS8L1 ZEB2 ANLN NUMB MACF1 MAP3K13 RAPGEF2 MUSK | 7.61e-04 | 494 | 123 | 10 | GO:0031346 |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | DAB2IP RIPK1 CHGA ZEB2 CHRNA7 PTPRC MAVS EIF4G1 PXN LRP4 MAP3K13 RAPGEF2 CHRFAM7A MUSK | 7.62e-04 | 879 | 123 | 14 | GO:0045937 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | DAB2IP RIPK1 CHGA ZEB2 CHRNA7 PTPRC MAVS EIF4G1 PXN LRP4 MAP3K13 RAPGEF2 CHRFAM7A MUSK | 7.62e-04 | 879 | 123 | 14 | GO:0010562 |
| GeneOntologyBiologicalProcess | memory | 8.10e-04 | 183 | 123 | 6 | GO:0007613 | |
| GeneOntologyBiologicalProcess | dendrite development | 9.10e-04 | 335 | 123 | 8 | GO:0016358 | |
| GeneOntologyBiologicalProcess | ERK1 and ERK2 cascade | 9.11e-04 | 418 | 123 | 9 | GO:0070371 | |
| GeneOntologyBiologicalProcess | membrane biogenesis | 9.54e-04 | 73 | 123 | 4 | GO:0044091 | |
| GeneOntologyBiologicalProcess | brainstem development | 9.65e-04 | 8 | 123 | 2 | GO:0003360 | |
| GeneOntologyBiologicalProcess | cognition | 9.90e-04 | 423 | 123 | 9 | GO:0050890 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | 1.04e-03 | 515 | 123 | 10 | GO:0072594 | |
| GeneOntologyBiologicalProcess | axonal transport | 1.06e-03 | 75 | 123 | 4 | GO:0098930 | |
| GeneOntologyBiologicalProcess | growth | DAB2IP ABL2 EAF2 NLGN4Y NACA SYT2 ZEB2 NLGN4X EIF4G1 VPS13A LRP4 MACF1 TMEM108 MAP3K13 UNC79 MUSK RASAL2 | 1.06e-03 | 1235 | 123 | 17 | GO:0040007 |
| GeneOntologyBiologicalProcess | developmental growth | ABL2 NLGN4Y NACA SYT2 ZEB2 NLGN4X VPS13A LRP4 MACF1 TMEM108 MAP3K13 UNC79 MUSK RASAL2 | 1.07e-03 | 911 | 123 | 14 | GO:0048589 |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 1.10e-03 | 130 | 123 | 5 | GO:0060079 | |
| GeneOntologyBiologicalProcess | negative regulation of protein catabolic process | 1.14e-03 | 131 | 123 | 5 | GO:0042177 | |
| GeneOntologyCellularComponent | asymmetric synapse | ANK2 ANK3 MAP1A NLGN4Y PCLO CHRNA7 SHANK2 NLGN4X LRP4 NUMB MACF1 TMEM108 BSN IGSF21 CHRFAM7A | 1.40e-07 | 477 | 123 | 15 | GO:0032279 |
| GeneOntologyCellularComponent | postsynaptic specialization | ANK2 ANK3 MAP1A NLGN4Y PCLO CHRNA7 SHANK2 NLGN4X LRP4 NUMB MACF1 TMEM108 BSN IGSF21 CHRFAM7A | 2.76e-07 | 503 | 123 | 15 | GO:0099572 |
| GeneOntologyCellularComponent | neuron to neuron synapse | ANK2 ANK3 MAP1A NLGN4Y PCLO CHRNA7 SHANK2 NLGN4X LRP4 NUMB MACF1 TMEM108 BSN IGSF21 CHRFAM7A | 4.53e-07 | 523 | 123 | 15 | GO:0098984 |
| GeneOntologyCellularComponent | inhibitory synapse | 9.77e-07 | 31 | 123 | 5 | GO:0060077 | |
| GeneOntologyCellularComponent | postsynapse | ABL2 ANK2 ANK3 MAP1A NLGN4Y PCLO SH3GLB2 CHRNA7 SHANK2 NLGN4X EIF4G1 LRP4 NUMB MACF1 TMEM108 RAPGEF2 BSN IGSF21 CHRFAM7A MUSK | 2.00e-06 | 1018 | 123 | 20 | GO:0098794 |
| GeneOntologyCellularComponent | postsynaptic density | ANK2 ANK3 MAP1A NLGN4Y PCLO SHANK2 NLGN4X LRP4 NUMB MACF1 TMEM108 BSN IGSF21 | 2.63e-06 | 451 | 123 | 13 | GO:0014069 |
| GeneOntologyCellularComponent | glycinergic synapse | 5.14e-06 | 20 | 123 | 4 | GO:0098690 | |
| GeneOntologyCellularComponent | spine apparatus membrane | 1.03e-04 | 3 | 123 | 2 | GO:0098897 | |
| GeneOntologyCellularComponent | postsynaptic membrane | ANK2 ANK3 NLGN4Y CHRNA7 SHANK2 NLGN4X TMEM108 IGSF21 CHRFAM7A MUSK | 1.43e-04 | 405 | 123 | 10 | GO:0045211 |
| GeneOntologyCellularComponent | dendrite | DAB2IP ABL2 ANK3 MAP1A NLGN4Y PCLO CHRNA7 SHANK2 NLGN4X HRH1 LRP4 NUMB TMEM108 BSN CHRFAM7A | 1.58e-04 | 858 | 123 | 15 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | DAB2IP ABL2 ANK3 MAP1A NLGN4Y PCLO CHRNA7 SHANK2 NLGN4X HRH1 LRP4 NUMB TMEM108 BSN CHRFAM7A | 1.62e-04 | 860 | 123 | 15 | GO:0097447 |
| GeneOntologyCellularComponent | synaptic membrane | ANK2 ANK3 NLGN4Y CHRNA7 SHANK2 NLGN4X LRP4 TMEM108 BSN IGSF21 CHRFAM7A MUSK | 1.71e-04 | 583 | 123 | 12 | GO:0097060 |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 2.04e-04 | 4 | 123 | 2 | GO:0098983 | |
| GeneOntologyCellularComponent | costamere | 2.82e-04 | 22 | 123 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | neuromuscular junction | 5.28e-04 | 112 | 123 | 5 | GO:0031594 | |
| GeneOntologyCellularComponent | pericentriolar material | 5.85e-04 | 28 | 123 | 3 | GO:0000242 | |
| GeneOntologyCellularComponent | somatodendritic compartment | DAB2IP ABL2 ANK3 MAP1A NLGN4Y PCLO CHRNA7 SHANK2 NLGN4X VPS13A HRH1 LRP4 NUMB TMEM108 RAPGEF2 BSN CHRFAM7A | 8.58e-04 | 1228 | 123 | 17 | GO:0036477 |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 9.40e-04 | 8 | 123 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | spine apparatus | 1.20e-03 | 9 | 123 | 2 | GO:0097444 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.23e-03 | 201 | 123 | 6 | GO:0099634 | |
| GeneOntologyCellularComponent | bleb | 1.50e-03 | 10 | 123 | 2 | GO:0032059 | |
| GeneOntologyCellularComponent | anchoring junction | ANK2 ANK3 PCDHA12 PRAG1 CDC42BPB ZYX PTPRC AHNAK MDC1 PXN NUMB RAPGEF2 IGSF21 ARHGAP21 | 1.81e-03 | 976 | 123 | 14 | GO:0070161 |
| GeneOntologyCellularComponent | main axon | 1.90e-03 | 89 | 123 | 4 | GO:0044304 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 2.31e-03 | 94 | 123 | 4 | GO:0044291 | |
| GeneOntologyCellularComponent | symmetric synapse | 2.57e-03 | 13 | 123 | 2 | GO:0032280 | |
| GeneOntologyCellularComponent | presynaptic cytoskeleton | 2.98e-03 | 14 | 123 | 2 | GO:0099569 | |
| GeneOntologyCellularComponent | nuclear pore | 3.00e-03 | 101 | 123 | 4 | GO:0005643 | |
| GeneOntologyCellularComponent | chromaffin granule | 3.43e-03 | 15 | 123 | 2 | GO:0042583 | |
| GeneOntologyCellularComponent | PcG protein complex | 3.56e-03 | 52 | 123 | 3 | GO:0031519 | |
| GeneOntologyCellularComponent | excitatory synapse | 3.69e-03 | 107 | 123 | 4 | GO:0060076 | |
| HumanPheno | Abnormal columella morphology | 2.46e-05 | 97 | 47 | 7 | HP:0009929 | |
| HumanPheno | Abnormality of the anterior commissure | 2.51e-05 | 7 | 47 | 3 | HP:0030301 | |
| MousePheno | failure of neuromuscular synapse presynaptic differentiation | 5.79e-08 | 6 | 112 | 4 | MP:0001054 | |
| MousePheno | abnormal synapse morphology | ANK2 PCLO CHRNA7 SHANK2 LRP4 BSN TMEM184B IGSF21 CHRFAM7A MUSK | 1.24e-05 | 224 | 112 | 10 | MP:0009538 |
| MousePheno | abnormal olfaction | 4.80e-05 | 50 | 112 | 5 | MP:0001984 | |
| MousePheno | airway basal cell hyperplasia | 6.36e-05 | 2 | 112 | 2 | MP:0011115 | |
| MousePheno | abnormal airway basal cell differentiation | 6.36e-05 | 2 | 112 | 2 | MP:0011114 | |
| MousePheno | abnormal airway basal cell morphology | 6.36e-05 | 2 | 112 | 2 | MP:0011113 | |
| MousePheno | impaired olfaction | 7.95e-05 | 29 | 112 | 4 | MP:0008544 | |
| MousePheno | abnormal olfactory system physiology | 9.86e-05 | 58 | 112 | 5 | MP:0001983 | |
| Domain | NLGN4 | 3.89e-05 | 2 | 117 | 2 | IPR030025 | |
| Domain | Znf_piccolo | 3.89e-05 | 2 | 117 | 2 | IPR008899 | |
| Domain | zf-piccolo | 3.89e-05 | 2 | 117 | 2 | PF05715 | |
| Domain | DUF3498 | 1.16e-04 | 3 | 117 | 2 | IPR021887 | |
| Domain | DUF3498 | 1.16e-04 | 3 | 117 | 2 | PF12004 | |
| Domain | WH2 | 1.26e-04 | 16 | 117 | 3 | PF02205 | |
| Domain | WH2_dom | 2.93e-04 | 21 | 117 | 3 | IPR003124 | |
| Domain | Znf_FYVE_PHD | 3.28e-04 | 147 | 117 | 6 | IPR011011 | |
| Domain | PDZ | 3.78e-04 | 151 | 117 | 6 | PS50106 | |
| Domain | Nlgn | 3.84e-04 | 5 | 117 | 2 | IPR000460 | |
| Domain | PDZ | 3.92e-04 | 152 | 117 | 6 | IPR001478 | |
| Domain | WH2 | 4.41e-04 | 24 | 117 | 3 | PS51082 | |
| Domain | DEATH | 6.28e-04 | 27 | 117 | 3 | SM00005 | |
| Domain | Death | 1.14e-03 | 33 | 117 | 3 | PF00531 | |
| Domain | ZU5 | 1.36e-03 | 9 | 117 | 2 | SM00218 | |
| Domain | PH_dom-like | DAB2IP EPS8L1 CDC42BPB SPRED3 ANLN NUMB ARHGAP21 RASAL2 GULP1 | 1.45e-03 | 426 | 117 | 9 | IPR011993 |
| Domain | ZU5 | 1.69e-03 | 10 | 117 | 2 | PS51145 | |
| Domain | Death_domain | 1.72e-03 | 38 | 117 | 3 | IPR000488 | |
| Domain | DEATH_DOMAIN | 1.72e-03 | 38 | 117 | 3 | PS50017 | |
| Domain | PDZ | 1.95e-03 | 141 | 117 | 5 | PF00595 | |
| Domain | PTB | 2.00e-03 | 40 | 117 | 3 | SM00462 | |
| Domain | PTB/PI_dom | 2.15e-03 | 41 | 117 | 3 | IPR006020 | |
| Domain | Kinase-like_dom | ABL2 RIPK1 PRAG1 MAP3K6 CDC42BPB PXK MACF1 MAP3K13 MUSK MAST3 | 2.17e-03 | 542 | 117 | 10 | IPR011009 |
| Domain | PDZ | 2.40e-03 | 148 | 117 | 5 | SM00228 | |
| Domain | ZU5 | 2.46e-03 | 12 | 117 | 2 | PF00791 | |
| Domain | ZU5_dom | 2.46e-03 | 12 | 117 | 2 | IPR000906 | |
| Domain | - | 2.55e-03 | 150 | 117 | 5 | 2.30.42.10 | |
| Domain | Carboxylesterase_B_CS | 2.90e-03 | 13 | 117 | 2 | IPR019819 | |
| Domain | - | 3.23e-03 | 391 | 117 | 8 | 2.30.29.30 | |
| Domain | RasGAP | 3.37e-03 | 14 | 117 | 2 | SM00323 | |
| Domain | CARBOXYLESTERASE_B_2 | 3.37e-03 | 14 | 117 | 2 | PS00941 | |
| Domain | COesterase | 3.37e-03 | 14 | 117 | 2 | PF00135 | |
| Domain | CarbesteraseB | 3.37e-03 | 14 | 117 | 2 | IPR002018 | |
| Domain | RasGAP_CS | 3.37e-03 | 14 | 117 | 2 | IPR023152 | |
| Domain | Prot_kinase_dom | 3.66e-03 | 489 | 117 | 9 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 3.85e-03 | 493 | 117 | 9 | PS50011 | |
| Domain | RasGAP | 3.87e-03 | 15 | 117 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 3.87e-03 | 15 | 117 | 2 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 3.87e-03 | 15 | 117 | 2 | PS50018 | |
| Domain | - | 4.41e-03 | 16 | 117 | 2 | 1.10.506.10 | |
| Domain | ARM-type_fold | 5.51e-03 | 339 | 117 | 7 | IPR016024 | |
| Domain | RasGAP_dom | 5.58e-03 | 18 | 117 | 2 | IPR001936 | |
| Domain | BRCT | 6.21e-03 | 19 | 117 | 2 | PF00533 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | DAB2IP ABL2 ANK2 ANK3 MAP1A NLGN4Y PCLO PRAG1 SHANK2 NLGN4X AHNAK MACF1 RAPGEF2 RASAL2 | 2.24e-12 | 281 | 126 | 14 | 28706196 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | DAB2IP ANK3 COBLL1 SH3GLB2 NUP214 EPS8L1 ITPRID2 ZYX SHANK2 MAVS ANLN AHNAK EIF4G1 NAV2 PXN NUMB MACF1 ARHGAP21 | 2.62e-12 | 565 | 126 | 18 | 25468996 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ABL2 CEP85L COBLL1 CEP192 ITPRID2 RFX7 PRAG1 MAP3K6 ZYX FSIP2 ANLN AHNAK EIF4G1 NAV2 NUMB MACF1 RAPGEF2 ARHGAP21 MUSK PCM1 RASAL2 | 5.41e-12 | 861 | 126 | 21 | 36931259 |
| Pubmed | ABL2 ANK3 RIPK1 MAP1A COBLL1 NUP214 ITPRID2 POM121C CDC42BPB ZYX KHDRBS1 HGS NAV2 MACF1 RAPGEF2 MGA | 2.89e-11 | 486 | 126 | 16 | 20936779 | |
| Pubmed | USP34 ANK3 MUC16 CEP192 BIRC6 CDC42BPB USP19 MAVS AHNAK VPS13A RAPGEF2 MGA SPEN ARHGAP21 PCM1 RASAL2 | 2.41e-08 | 777 | 126 | 16 | 35844135 | |
| Pubmed | ASXL1 KLF8 NACA HMGXB4 ZNF521 PROSER1 NUP214 CEP192 RFX7 POM121C ZEB2 KHDRBS1 ZNF608 MDC1 HGS EIF4G1 TAF9 CABIN1 MGA SPEN PCM1 | 4.65e-08 | 1429 | 126 | 21 | 35140242 | |
| Pubmed | ANK2 PCLO BRD3 CCDC57 ZEB2 SHANK2 NDUFA12 KHDRBS1 PHF20L1 ZNF608 AHNAK EIF4G1 VPS13A H1-5 PKHD1 NAV2 MACF1 PADI6 BSN SPEN ARHGAP21 | 5.42e-08 | 1442 | 126 | 21 | 35575683 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DAB2IP USP34 NUP214 CEP192 POM121C PRAG1 BIRC6 CDC42BPB SHANK2 INF2 AHNAK EIF4G1 NAV2 PXN LRP4 CABIN1 SPEN ARHGAP21 | 1.05e-07 | 1105 | 126 | 18 | 35748872 |
| Pubmed | 1.17e-07 | 105 | 126 | 7 | 9628581 | ||
| Pubmed | 1.45e-07 | 225 | 126 | 9 | 12168954 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | BRD3 NUP214 ITPRID2 RFX7 ZYX USP19 QSOX1 SETD2 PTPRC ANLN MDC1 EIF4G1 SPEN CLUH PCM1 | 1.49e-07 | 774 | 126 | 15 | 15302935 |
| Pubmed | USP34 ANK2 ANK3 CEP85L ZNF521 SH3GLB2 CDC42BPB ZEB2 PPP2R5E KHDRBS1 EIF4G1 BTG3 LRP4 MACF1 RAPGEF2 CABIN1 ARHGAP21 PCM1 RASAL2 | 1.99e-07 | 1285 | 126 | 19 | 35914814 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP34 MIS18BP1 MAP1A SH3GLB2 TACC2 CEP192 ITPRID2 SETD2 MACF1 BSN TAF9 SPEN PCM1 | 2.42e-07 | 588 | 126 | 13 | 38580884 |
| Pubmed | COL6A3 ANK2 SH3GLB2 BIRC6 CDC42BPB PHF1 PPP2R5E SLMAP PXN MACF1 MGA ARHGAP21 | 2.84e-07 | 497 | 126 | 12 | 23414517 | |
| Pubmed | DAB2IP COBLL1 TACC2 ZYX MAVS ANLN EIF4G1 NAV2 PXN NUMB SPEN PCM1 | 3.22e-07 | 503 | 126 | 12 | 16964243 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 3.47e-07 | 123 | 126 | 7 | 26912792 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | MIS18BP1 HMGXB4 BRD3 ZEB2 PHC1 FSIP2 PHF20L1 ANLN MDC1 CABIN1 MGA SPEN DNMT3A | 3.53e-07 | 608 | 126 | 13 | 36089195 |
| Pubmed | USP34 NUP214 BIRC6 ZEB2 PHC1 ZNF608 AHNAK PXN MGA ARHGAP21 PCM1 | 3.91e-07 | 418 | 126 | 11 | 34709266 | |
| Pubmed | DAB2IP ANK2 ANK3 CDC42BPB ZEB2 SHANK2 EIF4G1 MACF1 RAPGEF2 BSN CABIN1 MGA UNC79 ARHGAP21 PCM1 RASAL2 | 4.38e-07 | 963 | 126 | 16 | 28671696 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ANK3 MAP1A NUP214 ITPRID2 POM121C MDC1 NUMB TSHZ1 BSN MGA SPEN | 5.17e-07 | 430 | 126 | 11 | 35044719 |
| Pubmed | DAB2IP AMPD3 ADGRV1 CDC42BPB GK NUMB MACF1 MAP3K13 RAPGEF2 ARHGAP21 GULP1 | 5.17e-07 | 430 | 126 | 11 | 32581705 | |
| Pubmed | MIS18BP1 ANK3 POM121C KHDRBS1 HGS NUMB MACF1 ARHGAP21 RASAL2 | 5.37e-07 | 263 | 126 | 9 | 34702444 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | ZNF521 PROSER1 NUP214 RFX7 POM121C ZEB2 ZNF608 MDC1 MGA SPEN | 6.60e-07 | 351 | 126 | 10 | 38297188 |
| Pubmed | The mouse kinome: discovery and comparative genomics of all mouse protein kinases. | 9.21e-07 | 6 | 126 | 3 | 15289607 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | USP34 ABL2 RIPK1 CEP192 PRAG1 MAP3K6 ZYX NDUFA12 ANLN EIF4G1 PXN NUMB MAP3K13 ARHGAP21 MAST3 | 1.14e-06 | 910 | 126 | 15 | 36736316 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KLF8 ANK3 MCPH1 NLGN4Y CEP192 SYT2 ADGRV1 CCDC57 ATP10A CDC42BPB SHANK2 ZNF608 INF2 NUMB MACF1 RAPGEF2 PCM1 NPAS2 GULP1 | 1.81e-06 | 1489 | 126 | 19 | 28611215 |
| Pubmed | ABL2 ANK2 ANK3 RIPK1 COBLL1 NUP214 AHNAK HGS EIF4G1 NUMB MACF1 ARHGAP21 RASAL2 | 1.92e-06 | 708 | 126 | 13 | 39231216 | |
| Pubmed | 2.15e-06 | 103 | 126 | 6 | 10574462 | ||
| Pubmed | DAB2IP ASXL1 NUP214 CEP192 ZEB2 USP19 PPP2R5E MACF1 SPEN ARHGAP21 | 2.49e-06 | 407 | 126 | 10 | 12693553 | |
| Pubmed | USP34 NACA NUP214 BIRC6 SETD2 MAVS ANLN MDC1 HGS SMG9 MGA CLUH PCM1 | 2.80e-06 | 733 | 126 | 13 | 34672954 | |
| Pubmed | USP34 MAP1A HMGXB4 BRD3 POM121C SETD2 PPP2R5E ZNF608 RTL9 H1-5 LRP4 MACF1 RAPGEF2 TAF9 MGA PCM1 | 2.97e-06 | 1116 | 126 | 16 | 31753913 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 3.05e-06 | 170 | 126 | 7 | 23314748 | |
| Pubmed | 3.84e-06 | 9 | 126 | 3 | 23986861 | ||
| Pubmed | ANK2 ANK3 MAP1A PCLO CDC42BPB PPP2R5E SHANK2 NDUFA12 KHDRBS1 C12orf50 INF2 EIF4G1 MACF1 RAPGEF2 BSN ARHGAP21 PCM1 RASAL2 | 4.25e-06 | 1431 | 126 | 18 | 37142655 | |
| Pubmed | MIS18BP1 SH3GLB2 BRD3 ZYX PHC1 ZNF608 ANLN AHNAK CABIN1 SPEN PCM1 DNMT3A | 4.26e-06 | 645 | 126 | 12 | 25281560 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MCPH1 INTS7 HMGXB4 BRD3 NUP214 RFX7 POM121C CREM SETD2 KHDRBS1 AHNAK MDC1 H1-5 TAF9 CABIN1 MGA SPEN | 4.56e-06 | 1294 | 126 | 17 | 30804502 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 5.14e-06 | 184 | 126 | 7 | 32908313 | |
| Pubmed | 5.22e-06 | 347 | 126 | 9 | 17114649 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 5.36e-06 | 444 | 126 | 10 | 34795231 | |
| Pubmed | DAB2IP ANK3 BRD3 CEP192 ITPRID2 BIRC6 CDC42BPB ZYX PPP2R5E PTPRC AHNAK HGS VPS13A PXN NUMB | 6.40e-06 | 1049 | 126 | 15 | 27880917 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 7.18e-06 | 361 | 126 | 9 | 26167880 | |
| Pubmed | 7.50e-06 | 11 | 126 | 3 | 26403076 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ANK2 MAP1A NACA TACC2 NUP214 POM121C ZYX SETD2 MAVS AHNAK NUMB MACF1 ARHGAP21 PCM1 | 7.85e-06 | 934 | 126 | 14 | 33916271 |
| Pubmed | INTS7 NACA HMGXB4 BRD3 ITPRID2 CDC42BPB SETD2 PPP2R5E SHANK2 NDUFA12 ANLN MDC1 EIF4G1 PXN NUMB MACF1 TAF9 SPEN | 7.87e-06 | 1497 | 126 | 18 | 31527615 | |
| Pubmed | 8.93e-06 | 371 | 126 | 9 | 15747579 | ||
| Pubmed | 9.13e-06 | 472 | 126 | 10 | 38943005 | ||
| Pubmed | Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. | 9.89e-06 | 37 | 126 | 4 | 27565344 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | ABL2 SH3GLB2 CEP192 BIRC6 CDC42BPB SHANK2 NDUFA12 LRP4 MACF1 TAF9 ARHGAP21 RASAL2 | 1.27e-05 | 719 | 126 | 12 | 35337019 |
| Pubmed | Advancing the understanding of autism disease mechanisms through genetics. | 1.29e-05 | 13 | 126 | 3 | 27050589 | |
| Pubmed | 1.29e-05 | 13 | 126 | 3 | 20498043 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 38070724 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 34453977 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 26999808 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 27129924 | ||
| Pubmed | Sensorimotor gating and spatial learning in α7-nicotinic receptor knockout mice. | 1.30e-05 | 2 | 126 | 2 | 23521765 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 28258105 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 19344760 | ||
| Pubmed | Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation. | 1.30e-05 | 2 | 126 | 2 | 23403927 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 29114104 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 33995108 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 32552811 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 24836856 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 15948184 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 35678315 | ||
| Pubmed | Functional role of alpha7 nicotinic receptor in physiological control of cutaneous homeostasis. | 1.30e-05 | 2 | 126 | 2 | 12628457 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 25157794 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 31202708 | ||
| Pubmed | Prenatal nicotine exposure alters lung function and airway geometry through α7 nicotinic receptors. | 1.30e-05 | 2 | 126 | 2 | 22246862 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 27471776 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 22688057 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 32028688 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 30429582 | ||
| Pubmed | A transgenic mouse model reveals fast nicotinic transmission in hippocampal pyramidal neurons. | 1.30e-05 | 2 | 126 | 2 | 21501254 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 21368056 | ||
| Pubmed | Role of Bassoon and Piccolo in Assembly and Molecular Organization of the Active Zone. | 1.30e-05 | 2 | 126 | 2 | 26793095 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 1400473 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 26937017 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 36603528 | ||
| Pubmed | Activation of α7nAChR Promotes Diabetic Wound Healing by Suppressing AGE-Induced TNF-α Production. | 1.30e-05 | 2 | 126 | 2 | 26650489 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 22848433 | ||
| Pubmed | Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice. | 1.30e-05 | 2 | 126 | 2 | 16650968 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 35413868 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 24462939 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 29261717 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 20332206 | ||
| Pubmed | Altered hippocampal circuit function in C3H alpha7 null mutant heterozygous mice. | 1.30e-05 | 2 | 126 | 2 | 18199426 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 22490926 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 23270857 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 18077004 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 19462340 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 16923147 | ||
| Pubmed | Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast Cancers. | 1.30e-05 | 2 | 126 | 2 | 27974415 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 11790782 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 37746145 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 19631623 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 23183221 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 15770102 | ||
| Pubmed | Active zone density is conserved during synaptic growth but impaired in aged mice. | 1.30e-05 | 2 | 126 | 2 | 21935939 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 24326163 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 24855039 | ||
| Interaction | AGAP2 interactions | DAB2IP ABL2 ANK2 ANK3 MAP1A PCLO PRAG1 SHANK2 AHNAK BTG3 MACF1 RAPGEF2 RASAL2 | 5.85e-10 | 210 | 124 | 13 | int:AGAP2 |
| Interaction | CDH1 interactions | DAB2IP ANK3 COBLL1 SH3GLB2 NUP214 EPS8L1 ITPRID2 ZYX SHANK2 MAVS ZNF608 ANLN AHNAK EIF4G1 NAV2 PXN NUMB MACF1 ARHGAP21 DNMT3A | 4.70e-08 | 768 | 124 | 20 | int:CDH1 |
| Interaction | H3C1 interactions | SOX11 ANK2 ANK3 COBLL1 NACA HMGXB4 BRD3 PHF1 SETD2 ANLN AHNAK MDC1 EIF4G1 H1-5 NAV2 PXN TAF9 CABIN1 MGA SPEN DNMT3A | 1.36e-07 | 901 | 124 | 21 | int:H3C1 |
| Interaction | CNTROB interactions | 8.87e-07 | 166 | 124 | 9 | int:CNTROB | |
| Interaction | YWHAH interactions | DAB2IP ABL2 CEP85L COBLL1 CEP192 ITPRID2 RFX7 PRAG1 MAP3K6 ANLN AHNAK EIF4G1 NAV2 NUMB MACF1 RAPGEF2 SUCO ARHGAP21 PCM1 RASAL2 MAST3 | 3.52e-06 | 1102 | 124 | 21 | int:YWHAH |
| Interaction | YWHAB interactions | DAB2IP ABL2 CEP85L COBLL1 CEP192 ITPRID2 RFX7 ZYX ANLN HGS EIF4G1 NAV2 NUMB MACF1 RAPGEF2 SUCO ARHGAP21 PCM1 RASAL2 MAST3 | 3.71e-06 | 1014 | 124 | 20 | int:YWHAB |
| Interaction | KCNA3 interactions | ABL2 ANK2 ANK3 RIPK1 COBLL1 NACA NUP214 AHNAK HGS EIF4G1 VPS13A PKHD1 NUMB MACF1 BSN SPEN ARHGAP21 RASAL2 | 6.37e-06 | 871 | 124 | 18 | int:KCNA3 |
| Interaction | NUP43 interactions | USP34 MIS18BP1 NUP214 ITPRID2 POM121C FSIP2 SETD2 PHF20L1 MAVS ZNF608 MDC1 EIF4G1 RAPGEF2 MGA SPEN | 7.02e-06 | 625 | 124 | 15 | int:NUP43 |
| Interaction | PHF21A interactions | USP34 KLF8 NUP214 BIRC6 ZEB2 ZYX AHNAK PXN MGA ARHGAP21 PCM1 | 9.02e-06 | 343 | 124 | 11 | int:PHF21A |
| Interaction | BTBD8 interactions | 9.11e-06 | 46 | 124 | 5 | int:BTBD8 | |
| Interaction | SHANK3 interactions | ANK2 ANK3 MAP1A NACA CDC42BPB QSOX1 SETD2 SHANK2 KHDRBS1 HGS H1-5 MACF1 RAPGEF2 | 1.19e-05 | 496 | 124 | 13 | int:SHANK3 |
| Interaction | ARL16 interactions | 1.23e-05 | 83 | 124 | 6 | int:ARL16 | |
| Interaction | YWHAQ interactions | DAB2IP ABL2 CEP85L COBLL1 CEP192 ITPRID2 RFX7 PPP2R5E ANLN EIF4G1 NAV2 NUMB MACF1 RAPGEF2 CABIN1 SUCO UNC79 ARHGAP21 PCM1 RASAL2 | 1.57e-05 | 1118 | 124 | 20 | int:YWHAQ |
| Interaction | SYNGAP1 interactions | DAB2IP ANK2 MAP1A BIRC6 SHANK2 SLMAP RAPGEF2 ARHGAP21 RASAL2 GULP1 | 2.05e-05 | 307 | 124 | 10 | int:SYNGAP1 |
| Interaction | CSNK2A1 interactions | ASXL1 RIPK1 NACA BRD3 BIRC6 CREM ZEB2 PHC1 PTPRC INF2 ANLN MDC1 HGS SLMAP MACF1 MAP3K13 MGA MAST3 | 2.24e-05 | 956 | 124 | 18 | int:CSNK2A1 |
| Interaction | OTUD7A interactions | 2.87e-05 | 58 | 124 | 5 | int:OTUD7A | |
| Interaction | BAG2 interactions | ASXL1 ABL2 RIPK1 BRD3 PHC1 MAVS ANLN AHNAK MDC1 HGS PXN SPEN ARHGAP21 RASAL2 | 2.94e-05 | 622 | 124 | 14 | int:BAG2 |
| Interaction | CHN2 interactions | 3.01e-05 | 97 | 124 | 6 | int:CHN2 | |
| Interaction | PPP1R9B interactions | ANK2 ANK3 MAP1A PCLO NACA SH3GLB2 ZYX ZC3H10 SHANK2 NDUFA12 ANLN NAV2 BSN PCM1 | 3.16e-05 | 626 | 124 | 14 | int:PPP1R9B |
| Interaction | RASGEF1B interactions | 3.31e-05 | 30 | 124 | 4 | int:RASGEF1B | |
| Interaction | ARHGAP42 interactions | 3.39e-05 | 60 | 124 | 5 | int:ARHGAP42 | |
| Interaction | TERF2IP interactions | HMGXB4 EPS8L1 PHC1 ZC3H10 SETD2 PPP2R5E ZNF608 ANLN MDC1 TAF9 MGA SPEN DNMT3A | 3.63e-05 | 552 | 124 | 13 | int:TERF2IP |
| Interaction | EZR interactions | ANK2 ANK3 COBLL1 SH3GLB2 PTPRC KHDRBS1 ANLN AHNAK HGS NUMB MACF1 ARHGAP21 RASAL2 | 3.70e-05 | 553 | 124 | 13 | int:EZR |
| Interaction | YWHAZ interactions | DAB2IP ASXL1 ABL2 CEP85L COBLL1 BRD3 TACC2 CEP192 ITPRID2 FSIP2 ANLN MDC1 NAV2 NUMB MACF1 RAPGEF2 SUCO ARHGAP21 PCM1 RASAL2 MAST3 | 5.24e-05 | 1319 | 124 | 21 | int:YWHAZ |
| Interaction | H3C3 interactions | MIS18BP1 HMGXB4 BRD3 ZEB2 PHC1 PHF1 FSIP2 ANLN MDC1 MGA SPEN DNMT3A | 5.57e-05 | 495 | 124 | 12 | int:H3C3 |
| Interaction | YWHAG interactions | DAB2IP ABL2 CEP85L COBLL1 CEP192 ITPRID2 RFX7 PRAG1 MAP3K6 ANLN EIF4G1 NAV2 NUMB MACF1 RAPGEF2 SUCO ARHGAP21 PCM1 RASAL2 MAST3 | 7.39e-05 | 1248 | 124 | 20 | int:YWHAG |
| Interaction | LPXN interactions | 7.82e-05 | 115 | 124 | 6 | int:LPXN | |
| Interaction | SLC6A4 interactions | DAB2IP AMPD3 ADGRV1 CDC42BPB GK NUMB MACF1 MAP3K13 RAPGEF2 ARHGAP21 GULP1 | 8.26e-05 | 437 | 124 | 11 | int:SLC6A4 |
| Interaction | VASP interactions | 8.68e-05 | 294 | 124 | 9 | int:VASP | |
| Interaction | CEP152 interactions | 1.22e-04 | 179 | 124 | 7 | int:CEP152 | |
| Interaction | TNIK interactions | 1.25e-04 | 381 | 124 | 10 | int:TNIK | |
| Interaction | LYN interactions | DAB2IP ANK2 ANK3 COBLL1 CDC42BPB PTPRC KHDRBS1 ANLN VPS13A PXN NUMB MACF1 ARHGAP21 RASAL2 | 1.40e-04 | 720 | 124 | 14 | int:LYN |
| Interaction | HDAC1 interactions | ZNF521 NUP214 BIRC6 CREM ZEB2 USP19 PHF1 PHF20L1 ZNF608 ANLN AHNAK PXN CABIN1 MGA SPEN ARHGAP21 PCM1 DNMT3A | 1.49e-04 | 1108 | 124 | 18 | int:HDAC1 |
| Interaction | MAP1LC3B interactions | ANK2 ANK3 MAP1A BRD3 BIRC6 USP19 MDC1 HGS H1-5 NUMB CLUH PCM1 | 1.53e-04 | 551 | 124 | 12 | int:MAP1LC3B |
| Interaction | DVL2 interactions | MIS18BP1 EAF2 COBLL1 NUP214 ADGRV1 SCNM1 SLMAP PXN NUMB MACF1 CLUH GULP1 | 1.69e-04 | 557 | 124 | 12 | int:DVL2 |
| Interaction | CRX interactions | 1.78e-04 | 254 | 124 | 8 | int:CRX | |
| Interaction | DTX2 interactions | 2.07e-04 | 330 | 124 | 9 | int:DTX2 | |
| Interaction | KDM1A interactions | USP34 MCPH1 SH3GLB2 NUP214 BIRC6 ZEB2 PHC1 PHF1 KHDRBS1 PHF20L1 ZNF608 AHNAK PXN MGA ARHGAP21 PCM1 | 2.15e-04 | 941 | 124 | 16 | int:KDM1A |
| Interaction | XPNPEP2 interactions | 2.24e-04 | 4 | 124 | 2 | int:XPNPEP2 | |
| Interaction | YWHAE interactions | DAB2IP ABL2 CEP85L COBLL1 TACC2 ITPRID2 PRAG1 ZYX PPP2R5E ANLN NAV2 NUMB MACF1 RAPGEF2 MGA ARHGAP21 PCM1 RASAL2 MAST3 | 2.40e-04 | 1256 | 124 | 19 | int:YWHAE |
| Interaction | UHRF2 interactions | 2.41e-04 | 200 | 124 | 7 | int:UHRF2 | |
| Interaction | SRGAP1 interactions | 2.61e-04 | 92 | 124 | 5 | int:SRGAP1 | |
| Cytoband | 1q24 | 2.22e-05 | 20 | 126 | 3 | 1q24 | |
| GeneFamily | PDZ domain containing | 4.64e-05 | 152 | 77 | 6 | 1220 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 7.88e-04 | 10 | 77 | 2 | 830 | |
| GeneFamily | Ubiquitin specific peptidases | 1.75e-03 | 56 | 77 | 3 | 366 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 1.81e-03 | 15 | 77 | 2 | 26 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.81e-03 | 15 | 77 | 2 | 529 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 4.65e-03 | 24 | 77 | 2 | 654 | |
| Coexpression | GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP | 5.01e-07 | 199 | 125 | 9 | M8381 | |
| Coexpression | GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_UP | 5.28e-06 | 199 | 125 | 8 | M7710 | |
| Coexpression | HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS | ASXL1 MIS18BP1 RIPK1 CEP192 ADGRV1 GK MAVS ANLN LRP4 DNMT3A GULP1 | 7.39e-06 | 432 | 125 | 11 | MM419 |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.23e-09 | 188 | 125 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-09 | 195 | 125 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-09 | 195 | 125 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | COVID-19_Mild-PLT_2|COVID-19_Mild / Disease Group and Platelet Clusters | 3.26e-08 | 173 | 125 | 8 | d11705e56b6b21eec963ea224717f27680c781ed | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-08 | 184 | 125 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.01e-08 | 191 | 125 | 8 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.60e-08 | 193 | 125 | 8 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.99e-08 | 200 | 125 | 8 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.99e-08 | 200 | 125 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19_Mild-PLT_2|World / Disease Group and Platelet Clusters | 5.12e-07 | 169 | 125 | 7 | 6abfdc8b437f19c03b408bedc245059d28c6ba6a | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 9.40e-07 | 185 | 125 | 7 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 9.40e-07 | 185 | 125 | 7 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-06 | 187 | 125 | 7 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-06 | 187 | 125 | 7 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-06 | 187 | 125 | 7 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 188 | 125 | 7 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 191 | 125 | 7 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 1.16e-06 | 191 | 125 | 7 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.16e-06 | 191 | 125 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.16e-06 | 191 | 125 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 1.20e-06 | 192 | 125 | 7 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.20e-06 | 192 | 125 | 7 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.20e-06 | 192 | 125 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.20e-06 | 192 | 125 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.20e-06 | 192 | 125 | 7 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-06 | 193 | 125 | 7 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-06 | 194 | 125 | 7 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.34e-06 | 195 | 125 | 7 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.38e-06 | 196 | 125 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 1.38e-06 | 196 | 125 | 7 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-06 | 196 | 125 | 7 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.38e-06 | 196 | 125 | 7 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | B_cells-Activate_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.48e-06 | 198 | 125 | 7 | a663082d7fbd6db11d3d3024bbb8ba00183e19f8 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.58e-06 | 200 | 125 | 7 | 7c2d499af60654b7b28f172ac2c914ad49fb74b4 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Cortical_neuron|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.58e-06 | 200 | 125 | 7 | 5b3df61ff421846ef4cabf1bd5355534c8b95509 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.58e-06 | 200 | 125 | 7 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.88e-06 | 159 | 125 | 6 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.54e-06 | 162 | 125 | 6 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.52e-06 | 166 | 125 | 6 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 8.05e-06 | 168 | 125 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 8.62e-06 | 170 | 125 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.84e-06 | 174 | 125 | 6 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.84e-06 | 174 | 125 | 6 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 176 | 125 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.12e-05 | 178 | 125 | 6 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 179 | 125 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 180 | 125 | 6 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-05 | 181 | 125 | 6 | 71e55acd1d8e4307e56534c74a50e7be4d1dda0d | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.23e-05 | 181 | 125 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | TCGA-Ovary-Primary_Tumor|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.24e-05 | 106 | 125 | 5 | 14f548be39cec604fbdae0382cbf434fa4049840 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.24e-05 | 106 | 125 | 5 | 939b80950d39cdc7149a05fdfb64c8810064cdb1 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.24e-05 | 106 | 125 | 5 | e9e1b55f32b3d5b9eeec94a997912e5c21c1fb48 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 182 | 125 | 6 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 1.31e-05 | 183 | 125 | 6 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.31e-05 | 183 | 125 | 6 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.31e-05 | 183 | 125 | 6 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.39e-05 | 185 | 125 | 6 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 185 | 125 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.44e-05 | 186 | 125 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.44e-05 | 186 | 125 | 6 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 186 | 125 | 6 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 1.48e-05 | 187 | 125 | 6 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.48e-05 | 187 | 125 | 6 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.48e-05 | 187 | 125 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.53e-05 | 188 | 125 | 6 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.53e-05 | 188 | 125 | 6 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.53e-05 | 188 | 125 | 6 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.53e-05 | 188 | 125 | 6 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.53e-05 | 188 | 125 | 6 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 1.53e-05 | 188 | 125 | 6 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.57e-05 | 189 | 125 | 6 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | IPF-Epithelial-Club|IPF / Disease state, Lineage and Cell class | 1.57e-05 | 189 | 125 | 6 | f3fcef008ef252b29ac6d567fef27f9acf9cd70f | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.57e-05 | 189 | 125 | 6 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.62e-05 | 190 | 125 | 6 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.62e-05 | 190 | 125 | 6 | 5f1863bce9400b7c932f0e4d0e012ec4e8d7e555 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.67e-05 | 191 | 125 | 6 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.67e-05 | 191 | 125 | 6 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.67e-05 | 191 | 125 | 6 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 1.67e-05 | 191 | 125 | 6 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 1.72e-05 | 192 | 125 | 6 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 1.72e-05 | 192 | 125 | 6 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.72e-05 | 192 | 125 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-05 | 192 | 125 | 6 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.72e-05 | 192 | 125 | 6 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 1.72e-05 | 192 | 125 | 6 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.72e-05 | 192 | 125 | 6 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.77e-05 | 193 | 125 | 6 | 8f4bf9a2fbedae35432dad96730b00c70185874c | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.77e-05 | 193 | 125 | 6 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-22|World / Primary Cells by Cluster | 1.77e-05 | 193 | 125 | 6 | 3b927d4b8ecb21a408424ef91a23746c21741f49 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.82e-05 | 194 | 125 | 6 | 28c5482da199bcee9e85258a88af453d9fdbd56a | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 194 | 125 | 6 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.82e-05 | 194 | 125 | 6 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-05 | 194 | 125 | 6 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.82e-05 | 194 | 125 | 6 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.82e-05 | 194 | 125 | 6 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 1.88e-05 | 195 | 125 | 6 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-05 | 195 | 125 | 6 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 1.88e-05 | 195 | 125 | 6 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.88e-05 | 195 | 125 | 6 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-05 | 196 | 125 | 6 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.70e-05 | 50 | 82 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Genes in the cancer module 547. | 2.23e-04 | 16 | 82 | 3 | MODULE_547 | |
| Computational | Genes in the cancer module 313. | 3.80e-04 | 19 | 82 | 3 | MODULE_313 | |
| Computational | Genes in the cancer module 240. | 4.44e-04 | 20 | 82 | 3 | MODULE_240 | |
| Computational | Genes in the cancer module 156. | 5.94e-04 | 22 | 82 | 3 | MODULE_156 | |
| Drug | Thimerosal | USP34 MIS18BP1 ANK2 MCPH1 COBLL1 PCLO ITPRID2 ADGRV1 RFX7 MAP3K6 FSIP2 SETD2 PHF20L1 EIF4G1 BTG3 RAPGEF2 TAF9 SPEN PCM1 DNMT3A GULP1 | 1.97e-06 | 1199 | 124 | 21 | ctd:D013849 |
| Drug | 2-Chloropyrazine [14508-49-7]; Down 200; 35uM; MCF7; HT_HG-U133A | 1.14e-05 | 194 | 124 | 8 | 3570_DN | |
| Drug | Flumethasone [2135-17-3]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.23e-05 | 196 | 124 | 8 | 3410_UP | |
| Drug | Terconazole [67915-31-5]; Up 200; 7.6uM; HL60; HT_HG-U133A | 1.23e-05 | 196 | 124 | 8 | 2484_UP | |
| Drug | Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.23e-05 | 196 | 124 | 8 | 2250_UP | |
| Disease | cutaneous melanoma, hair color | 5.96e-06 | 62 | 122 | 5 | EFO_0000389, EFO_0003924 | |
| Disease | cortical thickness | SOX11 MCPH1 TACC2 SYT2 ADGRV1 ADAMTSL3 PXK PKHD1 NAV2 LRP4 MACF1 TMEM108 USP35 CLUH ARHGAP21 MUSK | 1.46e-05 | 1113 | 122 | 16 | EFO_0004840 |
| Disease | serum gamma-glutamyl transferase measurement | MAP1A COBLL1 POM121C CDC42BPB ZYX SETD2 AHNAK PKHD1 NAV2 TSHZ1 CABIN1 IGSF21 ARHGAP21 MAST3 | 2.62e-05 | 914 | 122 | 14 | EFO_0004532 |
| Disease | Colorectal Carcinoma | ANK2 ADAMTSL3 ZEB2 NLGN4X EIF4G1 NPAP1 VPS13A H1-5 PKHD1 HRH1 IGSF21 RASAL2 | 3.58e-05 | 702 | 122 | 12 | C0009402 |
| Disease | C-reactive protein measurement | USP34 AMPD3 ANK3 MAP1A COBLL1 BRD3 CEP192 PRAG1 ZNF608 AHNAK PXN NUMB MACF1 BSN ARHGAP21 MUSK | 3.85e-05 | 1206 | 122 | 16 | EFO_0004458 |
| Disease | malignant pleural mesothelioma (is_implicated_in) | 1.01e-04 | 4 | 122 | 2 | DOID:7474 (is_implicated_in) | |
| Disease | Myasthenic Syndromes, Congenital | 1.31e-04 | 24 | 122 | 3 | C0751882 | |
| Disease | Malignant neoplasm of breast | ANK2 CEP85L TACC2 NUP214 MAP3K6 ZEB2 SETD2 PTPRC MACF1 MAP3K13 MMP10 SPEN RASAL2 DNMT3A | 1.46e-04 | 1074 | 122 | 14 | C0006142 |
| Disease | atrial fibrillation | 1.61e-04 | 371 | 122 | 8 | EFO_0000275 | |
| Disease | body fat percentage | AMPD3 COBLL1 BRD3 ADAMTSL3 POM121C PHF20L1 PKHD1 MACF1 UNC79 | 2.01e-04 | 488 | 122 | 9 | EFO_0007800 |
| Disease | cognitive disorder (implicated_via_orthology) | 2.52e-04 | 6 | 122 | 2 | DOID:1561 (implicated_via_orthology) | |
| Disease | rheumatoid arthritis (biomarker_via_orthology) | 2.52e-04 | 6 | 122 | 2 | DOID:7148 (biomarker_via_orthology) | |
| Disease | Autism spectrum disorder | 3.51e-04 | 7 | 122 | 2 | cv:C1510586 | |
| Disease | reticulocyte measurement | USP34 AMPD3 COBLL1 BRD3 BIRC6 ZEB2 PTPRC AHNAK EIF4G1 VPS13A BSN ARHGAP21 DNMT3A | 4.28e-04 | 1053 | 122 | 13 | EFO_0010700 |
| Disease | thalamus volume | 4.35e-04 | 85 | 122 | 4 | EFO_0006935 | |
| Disease | neuroimaging measurement | SOX11 AMPD3 ANK3 MCPH1 ZNF521 TACC2 POM121C SLMAP PKHD1 NAV2 MACF1 RAPGEF2 MUSK | 4.93e-04 | 1069 | 122 | 13 | EFO_0004346 |
| Disease | level of Phosphatidylcholine (18:0_20:5) in blood serum | 5.99e-04 | 9 | 122 | 2 | OBA_2045095 | |
| Disease | Inherited focal segmental glomerulosclerosis | 7.47e-04 | 10 | 122 | 2 | cv:CN327126 | |
| Disease | Focal segmental glomerulosclerosis | 7.47e-04 | 10 | 122 | 2 | cv:C0017668 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 8.17e-04 | 364 | 122 | 7 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | Lung Neoplasms | 8.40e-04 | 265 | 122 | 6 | C0024121 | |
| Disease | Bipolar Disorder | 8.49e-04 | 477 | 122 | 8 | C0005586 | |
| Disease | Malignant neoplasm of lung | 8.57e-04 | 266 | 122 | 6 | C0242379 | |
| Disease | Hereditary Nephrotic Syndromes, Autosomal Dominant | 9.10e-04 | 11 | 122 | 2 | cv:CN043612 | |
| Disease | smoking status measurement, forced expiratory volume | 9.10e-04 | 11 | 122 | 2 | EFO_0004314, EFO_0006527 | |
| Disease | metabolite measurement, body weight gain | 1.09e-03 | 12 | 122 | 2 | EFO_0004566, EFO_0004725 | |
| Disease | nicotine dependence (implicated_via_orthology) | 1.09e-03 | 12 | 122 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | chronotype measurement | USP34 ANK2 ANK3 ZNF521 PRAG1 BIRC6 PKHD1 TMEM108 TSHZ1 BSN NPAS2 | 1.10e-03 | 882 | 122 | 11 | EFO_0008328 |
| Disease | Familial idiopathic steroid-resistant nephrotic syndrome | 1.28e-03 | 13 | 122 | 2 | cv:C4273714 | |
| Disease | intraocular pressure measurement | 1.29e-03 | 509 | 122 | 8 | EFO_0004695 | |
| Disease | aspartate aminotransferase measurement | COBLL1 EVI2B BRD3 NUP214 POM121C PRAG1 BIRC6 PXK PTPRC IGSF21 NPAS2 | 1.34e-03 | 904 | 122 | 11 | EFO_0004736 |
| Disease | cortical surface area measurement | USP34 SOX11 ANK3 MCPH1 SYT2 ADGRV1 ADAMTSL3 PPP2R5E MDC1 PKHD1 NAV2 MACF1 USP35 ARHGAP21 | 1.35e-03 | 1345 | 122 | 14 | EFO_0010736 |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 1.63e-03 | 121 | 122 | 4 | EFO_0004612, EFO_0005271 | |
| Disease | reaction time measurement | 1.69e-03 | 658 | 122 | 9 | EFO_0008393 | |
| Disease | waist-hip ratio | AMPD3 ANK3 COBLL1 HMGXB4 CEP192 RFX7 ADAMTSL3 BIRC6 PHC1 AHNAK ARHGAP21 DNMT3A NPAS2 | 1.71e-03 | 1226 | 122 | 13 | EFO_0004343 |
| Disease | Autosomal recessive primary microcephaly | 1.72e-03 | 15 | 122 | 2 | cv:C3711387 | |
| Disease | irritable bowel syndrome symptom measurement | 1.80e-03 | 58 | 122 | 3 | EFO_0021536 | |
| Disease | acne | 1.83e-03 | 125 | 122 | 4 | EFO_0003894 | |
| Disease | alcohol consumption measurement | COBLL1 PCLO ZNF521 BRD3 ADGRV1 BIRC6 CHRNA7 ZNF608 EIF4G1 PKHD1 MGA CHRFAM7A NPAS2 | 1.92e-03 | 1242 | 122 | 13 | EFO_0007878 |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 1.96e-03 | 16 | 122 | 2 | C0751885 | |
| Disease | cup-to-disc ratio measurement | 2.12e-03 | 430 | 122 | 7 | EFO_0006939 | |
| Disease | lysophosphatidylcholine measurement | 2.18e-03 | 62 | 122 | 3 | EFO_0010224 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 2.21e-03 | 17 | 122 | 2 | C0751883 | |
| Disease | Acute myeloid leukemia | 2.21e-03 | 17 | 122 | 2 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 2.21e-03 | 17 | 122 | 2 | 601626 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 2.21e-03 | 17 | 122 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | smoking cessation | 2.37e-03 | 325 | 122 | 6 | EFO_0004319 | |
| Disease | spine bone size | 2.48e-03 | 18 | 122 | 2 | EFO_0004508 | |
| Disease | neuroticism measurement, cognitive function measurement | 2.49e-03 | 566 | 122 | 8 | EFO_0007660, EFO_0008354 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 2.77e-03 | 19 | 122 | 2 | C0751884 | |
| Disease | Juvenile Myelomonocytic Leukemia | 2.77e-03 | 19 | 122 | 2 | C0349639 | |
| Disease | response to methotrexate, neurotoxicity | 2.77e-03 | 19 | 122 | 2 | EFO_0011057, GO_0031427 | |
| Disease | schizophrenia (implicated_via_orthology) | 2.84e-03 | 68 | 122 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | X-24309 measurement | 3.07e-03 | 20 | 122 | 2 | EFO_0800872 | |
| Disease | hematocrit | AMPD3 COBLL1 ADGRV1 PXK PKHD1 SMG9 NUMB BSN ARHGAP21 MUSK DNMT3A | 3.20e-03 | 1011 | 122 | 11 | EFO_0004348 |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 3.38e-03 | 148 | 122 | 4 | C0279702 | |
| Disease | level of Phosphatidylcholine (16:0_20:4) in blood serum | 3.38e-03 | 21 | 122 | 2 | OBA_2045076 | |
| Disease | red blood cell density measurement | 3.62e-03 | 880 | 122 | 10 | EFO_0007978 | |
| Disease | Autosomal Recessive Primary Microcephaly | 3.71e-03 | 22 | 122 | 2 | C3711387 | |
| Disease | Primary microcephaly | 3.71e-03 | 22 | 122 | 2 | C0431350 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.71e-03 | 152 | 122 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | JT interval | 3.76e-03 | 248 | 122 | 5 | EFO_0007885 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MSSAPTTPPSVDKVD | 1 | Q16537 | |
| PAPAAPMVSKGAESS | 426 | Q15059 | |
| VAAEPPPIKSAVQTM | 4136 | Q9NR09 | |
| PKDPAVISKSPSMAQ | 66 | Q9Y6K1 | |
| VPLPTSSISPAKMAN | 1046 | P42684 | |
| PKDAMTLPASSVPHI | 1716 | Q8WXG9 | |
| PFLSISSPKVSMPDV | 3406 | Q09666 | |
| MPSLEISAPKVTAPD | 4906 | Q09666 | |
| SVSSPDDAMVSPLKP | 811 | Q53SF7 | |
| TMKDPVNVTPSSTPE | 836 | Q8IXJ9 | |
| TAFSSPMEKDITPDP | 521 | O60312 | |
| LASVEMSAVAPPPAS | 366 | P36544 | |
| AASPAMSPTTPVVTG | 101 | Q01432 | |
| MKSPTNTTPHVPAEG | 586 | O00391 | |
| LKTSPPPAIATTIAM | 641 | Q9NVH2 | |
| HSMTDDPPTTKPLTA | 91 | Q9UI09 | |
| PTSTPTKLMAEASTP | 426 | Q99743 | |
| KPITMTIPVPKASSD | 1231 | Q01484 | |
| KAMIVPSSPSKTPEE | 3786 | Q01484 | |
| EPLVPTKSVPSGSEM | 271 | P09238 | |
| HAVSQPAISPSPKAM | 596 | Q9NRJ5 | |
| PAISPSPKAMVARVV | 601 | Q9NRJ5 | |
| KSPSMEPSAATPFRV | 61 | Q5VWQ8 | |
| PSMKTERPPASTSVA | 541 | Q8WXI7 | |
| MPASAQSTKSPDISP | 6121 | Q8WXI7 | |
| PLSDPTYATVKMTSP | 76 | Q6TGC4 | |
| SPDDSTVKMASPPPS | 986 | P78559 | |
| PNMDKNPTTPSSVIF | 1016 | Q6P0N0 | |
| KSSRMTPFPATSAAP | 1111 | Q14676 | |
| MSSVKTPETVVPTAP | 1316 | Q14676 | |
| ANSLPSKVPTTLMPV | 291 | Q7Z434 | |
| AMFVSPASSPPVAKL | 761 | Q8NEM0 | |
| AEPESVSSPPTLHMK | 2956 | Q8IWI9 | |
| PESSLFSPMPSEEKA | 166 | Q9NQW6 | |
| TFHPAPSVPEKSMAD | 1916 | Q9UPA5 | |
| APVSSKTPSTKEMHP | 1561 | Q5CZC0 | |
| KVHPPMPSSLSAEAQ | 866 | O95382 | |
| PMPVPTESSSQKTAV | 1136 | Q9Y6V0 | |
| FSSMPDPVDPTTVTK | 1261 | Q15154 | |
| ASLPDAKAKSPPTMV | 201 | Q96PD5 | |
| DKPTMTIVSPLPNDS | 356 | P34910 | |
| PIPAMPKASIDSSLE | 791 | Q9UJF2 | |
| VKVDPTSMSPLEIPS | 216 | O95600 | |
| TSPAASVPTPAAMVA | 1196 | O94854 | |
| AMKPSFPPSTSAVKV | 571 | P35658 | |
| TMLLPASPAKAPETE | 506 | Q9UGU5 | |
| TQAPKPEASPSMSVA | 976 | Q9Y5S2 | |
| MSSVTSNKETDPPPP | 271 | P28290 | |
| LASVEMSAVAPPPAS | 276 | Q494W8 | |
| KAASMDPPRATEPVA | 1001 | Q27J81 | |
| LIPAPSMVPATDTKA | 641 | A8CG34 | |
| SMVPATDTKAPPTLQ | 646 | A8CG34 | |
| APSMVPATDTKAPPT | 251 | A6NF01 | |
| AAPAASSASPMFKPI | 301 | A6NF01 | |
| MIKTEPTSPTPSAFK | 606 | Q86XN7 | |
| PNKQKSAEPSPTVMS | 121 | P49023 | |
| EVAPTASPLSGSPKM | 561 | O43283 | |
| YVSTTTKVPPPDMTS | 606 | Q8NFZ3 | |
| MAPPTSIEVVAADTP | 141 | Q96ID5 | |
| MSETAPAETATPAPV | 1 | P16401 | |
| EPRHSPQVKMAPTSS | 2031 | Q9Y6J0 | |
| VKHSPSEDKMSPASP | 141 | Q96CJ1 | |
| SKMAHPESSETPTPG | 126 | I3L273 | |
| ITQVSAPPAGSMTPK | 196 | Q9UBP9 | |
| PSESVDNASMPPVKV | 2671 | P12111 | |
| PVVKPSMPETTALGA | 451 | P32189 | |
| PLKMSSPHAESQPSV | 606 | Q2TAC2 | |
| APSLPSSPEKMVLSQ | 2666 | Q12955 | |
| ESKPIMTSSEAFEPP | 261 | Q5SZL2 | |
| KEVTASMAPPTIPSA | 426 | Q04637 | |
| ATPVMPKPSSLSADT | 821 | O60307 | |
| PVSEPSVSHLVKPMT | 2251 | Q8TEP8 | |
| LLPPSATASVKMEPE | 86 | Q07666 | |
| PSQTPKEMKSPVVFS | 276 | P35367 | |
| MSTATGPEAAPKPSA | 1 | Q8TE68 | |
| EGTPPSIATMAVPTS | 146 | Q03060 | |
| VSLSPMPPSEVKLQS | 141 | Q9BWG6 | |
| YVSTTTKVPPPDMTS | 606 | Q8N0W4 | |
| PLASATEVPSTAPMS | 301 | Q3SYA9 | |
| AESPPKTDLMAFSPS | 761 | Q9UN75 | |
| LPMPDDSVEKVSSPS | 421 | A8MW92 | |
| SSAPMTKPVTVVAPQ | 346 | P49757 | |
| FPTDIPKSAPHSMTA | 481 | O43189 | |
| SHMTATTPETAKPPP | 1121 | Q8NET4 | |
| PIVAPATTTATMPIG | 11 | Q8N9I0 | |
| MPTSQSPAVKASIPA | 191 | Q16594 | |
| MDPSAKPSASQSPEK | 126 | P35716 | |
| SPSVSVIPEGSPTAM | 21 | Q9Y519 | |
| SATVSMLSVKPPGPE | 391 | Q8IVL1 | |
| TAEMVKPSTPSPSHE | 336 | Q9H0W8 | |
| PTTAAATMPVVPSVA | 301 | Q9NR46 | |
| KEGMPPTISASTSAP | 2716 | P08F94 | |
| TMPFSSLPPTDESIK | 516 | Q13546 | |
| PIMVPPDTSTLVSSA | 796 | Q9NZP6 | |
| SKPAIDTSDMNTTPP | 816 | Q9NZP6 | |
| RAPSPVVSPTEMNKE | 1706 | Q9UPX8 | |
| EMEVKPSSVTAAASP | 156 | Q14201 | |
| SDTLSKPSPMPVSQE | 41 | P10645 | |
| PPDILSSKSMTPTAE | 131 | Q8NA57 | |
| SSANIPPLKFTAPSM | 1216 | O75153 | |
| PVPMPAHIAVASSTT | 1371 | Q9Y4G8 | |
| SVATRTPMEHVTPKP | 441 | O94966 | |
| PKSVTMDSAPKPFTD | 2671 | Q96RL7 | |
| APFVSKSSMAPSQPE | 146 | Q6ZSR9 | |
| TGPTSFPSPVSVSMK | 3426 | Q96T58 | |
| SVSMKPDLPVSLPTQ | 3436 | Q96T58 | |
| APSPAPALVMALTTT | 401 | A0A1B0GUW6 | |
| LPSPVDKVAANTPSM | 146 | Q14BN4 | |
| ETPPSAAAAPIITME | 156 | Q2MJR0 | |
| EEPPAPSSTSVEKMF | 556 | Q9P2H5 | |
| DSSTMVEAAPPIPKS | 366 | Q96K83 | |
| KAEPMPSASSAPPAS | 291 | O14964 | |
| PESPVVSTPTKSMQA | 461 | Q7Z410 | |
| VDSFPPAPSMAVVAV | 356 | Q7Z7A4 | |
| GSMLPAKASPVAESP | 656 | P78364 | |
| PSKSPASFEIPASAM | 2391 | O95359 | |
| ASIVSSSPVKPMQRP | 941 | Q2KHR2 | |
| ATATAAPKMPESTPV | 531 | Q9UBS9 | |
| ASVPSSMLSSPDAPK | 1056 | Q86YV5 | |
| VVPKNSTLPMEETSP | 1071 | Q9BYW2 | |
| APIMTTVQSKTAPPT | 351 | Q9HBG4 | |
| KNMPSATISKAPSTP | 1146 | Q9ULD9 | |
| MAAPRPSPAISVSVS | 1 | Q15942 | |
| VAKTSPPVFSKPMDS | 56 | Q8NET8 | |
| PSTLPDPKAVSLMTA | 2291 | Q70CQ2 | |
| PAVSVPSGDLSMPVK | 36 | Q8N1Y9 | |
| PVSMAPVAVSVAPVA | 381 | Q96K80 | |
| SPVKPMDSITSPSIA | 731 | O60315 | |
| MEIQVPPSPTDVAKS | 246 | Q5T5U3 | |
| TTAKMPSVPLSSDPL | 36 | P08575 | |
| SLTPPPHKSNVSAME | 626 | Q6ZSZ6 | |
| GPAPAAMATTSSKPE | 116 | Q6UXF1 | |
| SAPSIVSMFVPAPEE | 1981 | Q9P2D8 | |
| FMHSPLPQTTAEKSP | 16 | P82987 | |
| ATGMSEKSPVLPNTP | 1661 | O75096 | |
| AALVMAPVAPKEPST | 481 | E9PAV3 | |
| ATPAPKQAPALSMTS | 901 | E9PAV3 | |
| KTFPPMTSSKPSVDI | 461 | O15146 | |
| MTSSKPSVDIPNLPS | 466 | O15146 |